Alpha-interferon treatment of clonal cytogenetic abnormalities arising after autologous bone marrow transplant for acute myelogenous leukemia
Colwill, R.; Dube, I.; Pantalony, D.; Messner, H.; Sutton, D.M.C.; Keating, A.
Clinical and Investigative Medicine 16(4 Suppl): B64
1993
ISSN/ISBN: 0147-958X Accession: 029970823
PDF emailed within 1 workday: $29.90
Related References
Talpaz, M.; Kantarjian, H.; Hester, J.; Champlin, R.; Deisseroth, A. 1993: Autologous in vivo purged bone marrow and peripheral stem cell transplant in chronic myelogenous Induction of cytogenetic response and interferon-alpha responsiveness Blood 82(10 Suppl 1): 378AImrie, K.; Dube, I.; Colwill, C.; Prince, M.; Keating, A. 1995: New clonal cytogenetic abnormalities detected after autologous bone marrow transplantation for acute myeloid leukemia may not confer an adverse prognosis Clinical and Investigative Medicine 18(4 Suppl): B65
Fayad, L.; Kantarjian, H.; O'brien, S.; Seong, D.; Albitar, M.; Keating, M.; Talpaz, M. 1996: Emergence of new clonal abnormalities following interferon-alpha complete cytogenetic response in patients with chronic myelogenous leukemia Report of three cases Blood 88(10 Suppl 1 Part 1-2): 235A
Harada, M.; Akashi, K.; Hayashi, S.; Eto, T.; Takamatsu, Y.; Teshima, T.; Hirota, Y.; Taniguchi, S.; Nagafuji, K.; Mizuno, S.; Gondo, H.; Niho, Y. 1997: Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission. the Fukouka Bone Marrow Transplant Group International Journal of Hematology 66(3): 297-301
Weiner, R.S.; Gale, R.P.; Horowitz, M.M.; Bortin, M.M. 1991: Impact of cytogenetic abnormalities on outcome of bone marrow transplants for acute myelogenous leukemia Experimental Hematology 19(6): 574
Califaretti, N.; Davidson, M.; Abraham, R.; Roitman, D.; Crump, M.; Keating, A. 1998: Autologous bone marrow transplant for acute myelogenous leukemia in second or subsequent remission Blood 92(10 Suppl 1 Part 1-2): 294A
Gale, R.P.; Horowitz, M.M.; Weiner, R.S.; Ash, R.C.; Atkinson, K.; Babu, R.; Dicke, K.A.; Klein, J.P.; Lowenberg, B.; Reiffers, J. 1995: Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission Bone Marrow Transplantation 16(2): 203-208
Higano, C.S.; Raskind, W.; Durnam, D.; Singer, J.W. 1990: Alpha interferon if induces cytogenetic remissions in patients who relapse with chronic myelogenous leukemia cml after allogeneic bone marrow transplantation bmt Journal of Cellular Biochemistry Suppl (14 Part A): 286
Legare, R.D.; Gribben, J.G.; Nadler, L.M.; Gilliland, D.G.ry 1995: Prediction of therapy-related acute myelogenous leukemia and myelodysplastic syndrome after autologous bone marrow transplant for lymphoma Blood 86(10 Suppl 1): 400A
Imrie, K.; Dube, I.; Prince, H.M.; Keating, A. 1995: The incidence and significance of acquired cytogenetic abnormalities following autologous bone marrow transplantation for acute myeloid leukemia Blood 86(10 Suppl 1): 949A
Legare, R.D.; Gribben, J.G.; Maragh, M.; Hermanowski-Vosatka, A.; Roach, S.; Tantravahi, R.; Nadler, L.M.; Gilliland, D.G. 1997: Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma American Journal of Hematology 56(1): 45-51
Nemunaitis, J.; Appelbaum, F.R.; Lilleby, K.; Buhles, W.C.; Rosenfeld, C.; Zeigler, Z.R.; Shadduck, R.K.; Singer, J.W.; Meyer, W.; Buckner, C.D. 1994: Phase i study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia Blood 83(12): 3473-3479
Eberlé, F.; Toiron, Y.; Camerlo, J.; Lafage, M.; Sainty, D.; Arnoulet, C.; Raineri, V.; Gabert, J.; Maraninchi, D.; Mannoni, P. 1995: Persistence of BCR/ABL mRNA-expressing bone-marrow cells in patients with chronic myelogenous leukemia in complete cytogenetic remission induced by interferon-alpha therapy Leukemia and Lymphoma 18(1-2): 153-157
Gotoh, A.; Miyazawa, K.; Uchida, Y.; Sashida, G.; Kawakubo, K.; Kuriyama, Y.; Ohyashiki, K. 2002: Bone marrow cytogenetic complete remission achieved by interferon-alpha plus cytarabine ocfosfate therapy in a patient with chronic myelogenous leukemia during extramedullary blast crisis International Journal of Hematology 75(2): 191-194
Whalen, V.L.; Jackson, J.D.; Jershin, B.; Bishop, M.R.; Tarantolo, S.; Bayever, E.; Iversen, P.; Kessinger, A.; Sharp, J.G.; Armitage, J.O.; Warkentin, P.I. 1994: Ex vivo treatment of autologous bone marrow with oligonucleotide OL p53 for acute myelogenous leukemia Experimental Hematology 22(8): 778